Aclaris Therapeutics, Inc. · NASDAQ:ACRS

Aclaris Therapeutics, Inc. shareholders

As of Sep 30, 2026, 161 institutions reported holding Aclaris Therapeutics, Inc., 87.3% of its shares. Largest: Ra Capital Management, L.P., BML Capital Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Aclaris Therapeutics, Inc.ChangeFiled
Ra Capital Management, L.P.12.7M8.0%no changeNov 16, 2026
BML Capital Management, LLC11M6.9%−1.02MNov 6, 2026
BlackRock10.4M6.5%+340KNov 13, 2026
Deep Track Capital, LP9.35M5.9%no changeNov 16, 2026
Frazier Life Sciences Management, L.P.8.73M5.5%+3.8MNov 16, 2026
Vanguard8.37M5.3%+31,909Nov 16, 2026
Fidelity7.05M4.4%+6.73MNov 10, 2026
Vivo Capital, LLC6.69M4.2%no changeNov 13, 2026
Mpm Bioimpact LLC5.18M3.3%+4.14MNov 16, 2026
Decheng Capital LLC4.04M2.5%no changeNov 13, 2026

Aclaris Therapeutics, Inc. insider trades